Journal article

ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats

Oliver A Garden, Linda Kidd, Angela M Mexas, Yu-Mei Chang, Unity Jeffery, Shauna L Blois, Jonathan E Fogle, Amy L MacNeill, George Lubas, Adam Birkenheuer, Simona Buoncompagni, Julien RS Dandrieux, Antonio Di Loria, Claire L Fellman, Barbara Glanemann, Robert Goggs, Jennifer L Granick, Dana N LeVine, Claire R Sharp, Saralyn Smith-Carr Show all

JOURNAL OF VETERINARY INTERNAL MEDICINE | WILEY | Published : 2019

Abstract

Immune-mediated hemolytic anemia (IMHA) is an important cause of morbidity and mortality in dogs. IMHA also occurs in cats, although less commonly. IMHA is considered secondary when it can be attributed to an underlying disease, and as primary (idiopathic) if no cause is found. Eliminating diseases that cause IMHA may attenuate or stop immune-mediated erythrocyte destruction, and adverse consequences of long-term immunosuppressive treatment can be avoided. Infections, cancer, drugs, vaccines, and inflammatory processes may be underlying causes of IMHA. Evidence for these comorbidities has not been systematically evaluated, rendering evidence-based decisions difficult. We identified and extra..

View full abstract